Samenvatting Leerjaar 2, Leerpakket 5, Klinisch Redeneren+VTH+AFP
Leerpakket5 AFP is meegenomen in de samenvatting.
Leerpakket 5 Verpleegtechnisch handelen is meegenomen in de samenvatting
Leerpakket 5 KT7 Neurorevalidatie is meegenomen in de samenvatting
LP5 Tentamen KT1, 5, 6 en 7
Inhoudsopgave
KT 1 Klinisch redeneren.................................................................................................................................. 4
Palliatieve zorg.....................................................................................................................................................5
Stadia palliatieve zorg..........................................................................................................................................5
Fasen palliatieve zorg...........................................................................................................................................5
Ziekgerichte- en symptoomgerichte palliatie.......................................................................................................6
Surprise question..................................................................................................................................................6
Meest voorkomende symptomen in de palliatieve fase......................................................................................7
Klinisch redeneren................................................................................................................................................7
Verschil curatieve en palliatieve zorg...................................................................................................................8
Dimensies palliatieve zorg....................................................................................................................................8
Thema’s palliatieve zorg......................................................................................................................................8
Slaapproblemen...................................................................................................................................................9
Vermoeidheid bij kanker....................................................................................................................................10
Soorten pijn........................................................................................................................................................11
Pijnverwerking....................................................................................................................................................12
Model van Loeser...............................................................................................................................................12
Meetinstrumenten pijn.......................................................................................................................................12
Interventies pijn..................................................................................................................................................13
Pijnmedicatie......................................................................................................................................................14
Psychische en sociale invloeden op pijn.............................................................................................................14
Symptomen en syndromen.................................................................................................................................15
Symptoommanagement....................................................................................................................................15
Spirituele zorg.....................................................................................................................................................15
Definitie spiritualiteit.....................................................................................................................................16
Ars moriendi model............................................................................................................................................16
Exacerbatie.........................................................................................................................................................18
Preventie en symptomen..............................................................................................................................18
Signaleren en interventies.............................................................................................................................19
Klinisch redeneren bij dyspneu...........................................................................................................................21
Obstipatie in de palliatieve fase.........................................................................................................................23
Anorexie en gewichtsverlies in de palliatieve fase.............................................................................................25
F- en G-culturen..................................................................................................................................................26
Voorbeelden F- en G-culturen.......................................................................................................................28
Evaluatie.............................................................................................................................................................28
Overdracht.........................................................................................................................................................29
,Spirituele zorgbehoeften....................................................................................................................................29
Klinisch redeneren bij vermoeidheid..................................................................................................................31
Definitie en uitingsvormen vermoeidheid.....................................................................................................31
Vroeg-signalering en probleemherkenning...................................................................................................31
Interventies en testvragen.............................................................................................................................32
Palliatief redeneren............................................................................................................................................33
Zelfmanagement................................................................................................................................................34
Casemanagement palliatieve zorg.....................................................................................................................35
Zorgvoorzieningen palliatieve zorg....................................................................................................................35
Ketenzorg...........................................................................................................................................................35
CVA en TIA..........................................................................................................................................................36
De acute fase CVA..........................................................................................................................................37
De revalidatie fase.........................................................................................................................................37
De chronische fase.........................................................................................................................................38
Preventie van een CVA/TIA............................................................................................................................39
LTA.................................................................................................................................................................40
LESA................................................................................................................................................................40
Mobiliteitstekort t.g.v. CVA................................................................................................................................40
Kwetsbaarheid bij ouderen................................................................................................................................42
Risico-inschatting en vroeg-signalering.........................................................................................................42
Van screening naar interventie.....................................................................................................................43
Syndroom...........................................................................................................................................................43
Drie D’s van de psychogeriatrie..........................................................................................................................44
Delier in de palliatieve fase................................................................................................................................44
Pathologie van dementie...................................................................................................................................44
Casemanagement dementie..............................................................................................................................46
Kwetsbaarheid bij ouderen...........................................................................................................................46
Dementiezorg................................................................................................................................................46
Casemanagement..........................................................................................................................................47
De CM professional........................................................................................................................................48
Portretten van mantelzorgers............................................................................................................................48
Mantelzorg.....................................................................................................................................................48
Palliatieve zorg bij dementie..............................................................................................................................49
Meetinstrumenten........................................................................................................................................49
Lijden bij dementie........................................................................................................................................49
Wilsbekwaamheid..............................................................................................................................................50
Overbelasting van de mantelzorger...................................................................................................................51
Technologie bij dementie thuis..........................................................................................................................52
Advance care planning (ACP).............................................................................................................................53
Timing ACP.....................................................................................................................................................54
Rol verpleegkundige bij ACP..........................................................................................................................54
Wilsverklaring....................................................................................................................................................54
Niet-reanimatiebeleid en abstinerend beleid.....................................................................................................55
STED....................................................................................................................................................................56
Palliatieve sedatie..............................................................................................................................................57
, Euthanasie en hulp bij zelfdoding......................................................................................................................59
Spiritualiteit in relatie tot het Jodendom...........................................................................................................60
Verpleegkundig leiderschap...............................................................................................................................61
Opname verpleeghuis dementie........................................................................................................................62
Stervensfase.......................................................................................................................................................63
Zorg in de stervensfase..................................................................................................................................63
Verpleegkundige interventies in de stervensfase.........................................................................................64
Zorgpad Stervensfase.........................................................................................................................................64
Rouw en verlies..................................................................................................................................................66
Rol professionals............................................................................................................................................68
Complementaire zorg.........................................................................................................................................69
Verstoord energieveld...................................................................................................................................69
Etherische oliën.............................................................................................................................................69
Massage.........................................................................................................................................................71
Ontspanningsoefeningen...............................................................................................................................72
Luisteren naar muziek...................................................................................................................................73
Spiritualiteit in relatie tot het Christendom.......................................................................................................74
Spiritualiteit in relatie tot de islam.....................................................................................................................76
KT1 AFP....................................................................................................................................................... 77
De celdeling: mitose en meiose..........................................................................................................................78
Carcinoom..........................................................................................................................................................79
Metaplasia.....................................................................................................................................................79
Dysplasia........................................................................................................................................................79
Neoplasia.......................................................................................................................................................80
Benigne tumoren...........................................................................................................................................80
Maligne tumoren...........................................................................................................................................80
Stadia van carcinoom en metastaseren........................................................................................................80
TNM-classificatie................................................................................................................................................81
Oorzaken en preventie carcinoom................................................................................................................82
Etiologische factoren/risicofactoren.............................................................................................................82
Premaligne afwijking.....................................................................................................................................82
Colorectaalcarcinoom........................................................................................................................................84
Symptomen colorectaalcarcinoom................................................................................................................86
Diagnostiek en behandeling colorectaalcarcinoom......................................................................................87
Zenuwstelsel.......................................................................................................................................................88
CVA.................................................................................................................................................................89
Dementie.......................................................................................................................................................90
Kwabben.............................................................................................................................................................91
Hersenbloedingen..............................................................................................................................................92
TIA......................................................................................................................................................................93
KT 1 Klinisch redeneren
Leerdoelen week 1:
Wat is palliatieve zorg
Stadia palliatieve zorg
The benefits of buying summaries with Stuvia:
Guaranteed quality through customer reviews
Stuvia customers have reviewed more than 700,000 summaries. This how you know that you are buying the best documents.
Quick and easy check-out
You can quickly pay through credit card or Stuvia-credit for the summaries. There is no membership needed.
Focus on what matters
Your fellow students write the study notes themselves, which is why the documents are always reliable and up-to-date. This ensures you quickly get to the core!
Frequently asked questions
What do I get when I buy this document?
You get a PDF, available immediately after your purchase. The purchased document is accessible anytime, anywhere and indefinitely through your profile.
Satisfaction guarantee: how does it work?
Our satisfaction guarantee ensures that you always find a study document that suits you well. You fill out a form, and our customer service team takes care of the rest.
Who am I buying these notes from?
Stuvia is a marketplace, so you are not buying this document from us, but from seller lisahagens1. Stuvia facilitates payment to the seller.
Will I be stuck with a subscription?
No, you only buy these notes for $6.53. You're not tied to anything after your purchase.